According to Blueprint Medicines 's latest financial reports the company's total assets are $1.04 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $1.04 B | -22.27% |
2022-12-31 | $1.34 B | 7.8% |
2021-12-31 | $1.25 B | -27.13% |
2020-12-31 | $1.71 B | 142.82% |
2019-12-31 | $0.70 B | 31.02% |
2018-12-31 | $0.54 B | -24.54% |
2017-12-31 | $0.71 B | 153.09% |
2016-12-31 | $0.28 B | 58.08% |
2015-12-31 | $0.17 B | 258.33% |
2014-12-31 | $49.92 M | 1107.38% |
2013-12-31 | $4.13 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Pacific Biosciences
PACB | $1.74 B | 66.41% | ๐บ๐ธ USA |
OPKO Health
OPK | $2.01 B | 91.73% | ๐บ๐ธ USA |
Acceleron Pharma XLRN | N/A | N/A | ๐บ๐ธ USA |
Isoray
ISR | $58.27 M | -94.45% | ๐บ๐ธ USA |